Serious adverse events reporting in recent randomised clinical trials in intensive care medicine – A methodological study protocol
Acta Anaesthesiologica Scandinavica · 2024-11 · 68 (10) · 1581-1587
DOI: 10.1111/aas.14512 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Acta Anaesthesiologica Scandinavica, online erschienen am 11.09.2024. Verfasst von Marie Qvist Jensen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Critical Care. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rigshospitalet.
Themen: Intensivpflege, Patientensicherheit
Abstract (Originalsprache)
Background
Serious adverse events (SAEs) are common in intensive care unit (ICU) patients. Reporting of SAEs in randomised clinical trials (RCTs) varies why underreporting is likely. We aim to describe the reporting of SAEs from 2020 onwards and to illustrate the recent reporting of SAEs published in major medical journals.
Methods
We will conduct a methodological study assessing pharmacological interventions in RCTs including adult ICU patients. We will search 10 general medical and critical care journals in PubMed. We will include all RCTs published from 2020 onwards. The primary research question is how many RCTs report SAEs in the primary publication. Secondary research questions include how SAEs are reported in the primary publication either as (1) proportion of patients experiencing one or more SAE, (2) all single events occurred, or (3) both strategies combined. We will assess the association between the proportion of patients with reported SAEs and the following trial characteristics: multicentred versus single‐centre RCTs, industry‐sponsored versus academic‐sponsored, published trial protocol versus unpublished work, blinding, trials sample size, and RCTs focusing on COVID‐19 patients versus other populations.
Discussion
The outlined methodological study will provide important information on the reporting of SAEs in recent drug trials in adult ICU patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Urology, Copenhagen University Hospital - Herlev, Copenhagen, Denmark.
ORCID-Profile: Marie Warrer Munch, Anders Granholm
Förderung
- Rigshospitalet
Zitieren
APA
Jensen, M. Q., Munch, M. W., Granholm, A., Møller, M. H., Bahrenkova, M., & Perner, A. (2024). Serious adverse events reporting in recent randomised clinical trials in intensive care medicine – A methodological study protocol. Acta Anaesthesiologica Scandinavica, 68(10), 1581-1587. https://doi.org/10.1111/aas.14512
Vancouver
Jensen MQ, Munch MW, Granholm A, Møller MH, Bahrenkova M, Perner A. Serious adverse events reporting in recent randomised clinical trials in intensive care medicine – A methodological study protocol. Acta Anaesthesiologica Scandinavica. 2024;68(10):1581-1587. doi:10.1111/aas.14512
BibTeX
@article{Jensen2024,
author = {Jensen, Marie Qvist and Munch, Marie Warrer and Granholm, Anders and Møller, Morten Hylander and Bahrenkova, Marina and Perner, Anders},
title = {Serious adverse events reporting in recent randomised clinical trials in intensive care medicine – A methodological study protocol},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2024},
volume = {68},
number = {10},
pages = {1581--1587},
doi = {10.1111/aas.14512}
}
EUVIMED